Philips launches DreamWisp to expand sleep solutions portfolio
Royal Philips, a health technology provider, has launched the new over-the-nose nasal mask DreamWisp, which allows sleep apnea patients to sleep in any position they want.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn MoreRoyal Philips, a health technology provider, has launched the new over-the-nose nasal mask DreamWisp, which allows sleep apnea patients to sleep in any position they want.
Olympus Medical Systems has announced that a patient with severe emphysema has been treated using endobronchial valve treatment with FDA-approved Spiration Valve System (SVS).
Third Pole Therapeutics, a privately held company developing and delivering transformative cardio-pulmonary therapies, has entered into a strategic collaboration to work with Actelion Pharmaceuticals, a Janssen pharmaceutical company of Johnson & Johnson.
Equivital has developed a healthcare wearable for the US military that can withstand environmental pressures to collect physiological data
El Camino Hospital today announced it is the first hospital in California to have successfully performed the new and recently Food and Drug Administration (FDA) approved lung valve treatment for patients with severe COPD/emphysema, an incurable lung disease that causes extreme breathing difficulty and constant discomfort for patients.
Given they contain many harmful chemicals, e-cigarettes may not be a healthy alternative to smoking but there is another type of tech that claims to be different
ResMed, a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.
The Breath Biopsy device is designed to diagnose cancer early from molecules exhaled by patients.
Medtronic has said that preliminary results from a prospective, multi-center study to identify patients at high risk for opioid-induced respiratory compromise offered easy-to-use risk prediction tool.
Vapotherm, a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress, announced the release of the next generation of its capital unit: the Precision Flow Hi-VNI system.